Samsrita Labs Limited (SAMSRITA) Share Price
BSE · Healthcare · Diagnostics & Research · ISIN INE579N01018
Key metrics
- Market Cap
- ₹29 Cr
- P/E Ratio
- —
- EPS
- -3.88
- Book Value
- 5.17
- P/B Ratio
- 2.45
- ROE
- -69.43%
- ROCE
- -5.77%
- Debt / Equity
- 0.14
- Net Margin
- -45,000.66%
- Revenue Growth
- —
- Profit Growth
- -2,765.79%
- Dividend Yield
- —
- 52W High
- ₹25.27
- 52W Low
- ₹10.15
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Samsrita Labs Limited
Samsrita Labs Limited operates as a biopharmaceutical company in India. It offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. The company is also involved in the stem cell research and therapy, including regenerative medicine, bio-artificial organ scaffold development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology for the body organs of the liver, pancreas, neural, cardiac, vascular, renal, and orthopedic systems. In addition, it engages in new drug discovery, targeting therapeutic areas, such as Wilson's disease, non-alcoholic steatohepatitis, neuropathic pain, cardiovascular disease, cystinosis, and Huntington's disease. Further, the company provides molecular prognosis and diagnostic services in the areas of cytogenetics, pharmacogenomics, pathology, radiology, hematology, biochemistry, microbiology, and others; and develops liver support devices, bioengineered implantable humanized nerve conduits, implantable nanochips carrying insulin-producing cells, and extracorporeal devices, as well as contract research and manufacturing services. Additionally, it offers molecular diagnostics services to patients, private consultants, academic and hospital services, hospitals, and other healthcare institutions. The company was formerly known as Dr. Habeebullah Life Sciences Limited and changed its name to Samsrita Labs Limited in October 2022. Samsrita Labs Limited was incorporated in 1996 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Employees
- 5
- Promoter Holding
- 77.99%
The full Samsrita Labs Limited analysis
Create a free account to open the complete SAMSRITA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.